By MarketNewsVideo Merck (MRK) was upgraded to buy by Bank of America/Merrill Lynch (BAC) as the firm believes that the current stock price provides investors with an attractive entry point. A $47 price target was issued. …read more
Source: FULL ARTICLE at Forbes Markets